Abstract:(109 of 130), respectively. In the same analysis corresponding specificities were 54% (13 negative scans of 24 benign lesions), 80% (103 of 129), and 84% (109 of 130).Clinical studies using indium-111 labelled F(ab')2 fragments of the anti-CEA monoclonal antibody F023C5 have been carried out by our group since November 1987.7 1012 We aimed to evaluate the role of planar and single photoemission computed tomography (SPECT) immunoscintigraphy images in the thoracic assessment of resectability. The present report… Show more
“…Such clinical evaluation, which also included physical examination, routine laboratory tests, and the measurement of serum tumor markers, 10,11 was supplemented by many nonroutine studies, including 104 67 Ga scans 12 and 142 anti-carcinoembryonic antigen (CEA) monoclonal antibody scintigraphies. 13,14 In contrast with several carefully staged patients, there were others for whom performing the baseline three-organ CT was impossible or unreasonable. Also, a small but significant number of patients refused to undergo what they considered a distressing test.…”
Section: Diagnostic Techniques Therapeutic Management and Documentamentioning
“…Such clinical evaluation, which also included physical examination, routine laboratory tests, and the measurement of serum tumor markers, 10,11 was supplemented by many nonroutine studies, including 104 67 Ga scans 12 and 142 anti-carcinoembryonic antigen (CEA) monoclonal antibody scintigraphies. 13,14 In contrast with several carefully staged patients, there were others for whom performing the baseline three-organ CT was impossible or unreasonable. Also, a small but significant number of patients refused to undergo what they considered a distressing test.…”
Section: Diagnostic Techniques Therapeutic Management and Documentamentioning
“…A new staging procedure, consisting of Indium-111 anti-carcinoembryonic antigen (CEA) monoclonal antibody scintigraphy [12], was added to the evaluation of all surgical candidates. Cell types and tumour stages were classified according to internationally adopted criteria [13,14].…”
Section: Patientsmentioning
confidence: 99%
“…The trend approached statistical significance in eight circumstances (SDS items 2, 5, 7, I feel down-hearted, blue and sad Morning is when I feel the best I have crying spells or feel like it I have trouble sleeping through the night I eat as much as I used do I enjoy looking at, talking to, and being with attractive women (or men) I notice that I am losing weight I have trouble with constipation My heart beats faster than usual I get tired for no reason My mind is as clear as it used to be I find it easy to do things I used to I am restless and can't keep still I feel hopeful about the future I am more irritable then usual I find it easy to make decisions I feel that I am pretty useful and needed My life is pretty full I feel that others would be better off if I were dead I still enjoy the things I used to do 65 36 92 55 47 20 54 90 96 49 50 35 73 57 66 42 66 51 114 50 49 37 31 37 41 14 29 25 24 49 38 30 37 37 38 41 42 45 8 43 3 28 3 19 14 22 14 6 4 16 24 31 10 25 9 28 16 19 3 25 16 32 7 22 31 48 35 12 5 17 21 37 13 12 19 21 8 16 6 14 8, 12,15,18,19), being significant at p<0.0025 in one case (item 19="I feel that others would be better off if I were dead"). Dichotomizing the sample into two groups with antithetical SDS responses (i.e.…”
In diverse human malignancies, including lung cancer, quality of life (QOL) affects the clinical outcome of patients. Many QOL dimensions, however, are influenced by physical status. The current study was undertaken to delineate the role of depression, a state of mind not necessarily influenced by somatic factors. All patients, seen for a newly diagnosed carcinoma of the lung, received a copy of the Self-rating Depression Scale (SDS) proposed by W.W.K. Zung. One hundred and thirty three patients were able and willing to complete the questionnaire. A depression index was calculated, as originally described. Nineteen other prognostically important variables were recorded and available for evaluation. Among the 95 patients who completed all 20 items included in the questionnaire, 53 had an SDS index < or = 50 (no depression), while 42 were moderately or severely depressed (SDS index >50). The survival of depressed patients was significantly lower (p=0.048). Diverse SDS subscales were associated with survival, in either univariate or multivariate analysis. SDS item 19, "I feel that others would be better off if I were dead", emerged as the most significant one. A multivariate model of survival, constructed using only SDS data, had a global Chi-squared value of 29.78, and a p-value of 0.00023. Based on this evidence, it appears that a relationship does exist between patients' depression and prognosis, at least in lung cancer. Further studies are needed to clarify the prognostic effect of depression in more specific (and homogeneous) subgroups of patients.
“…33 Unfortunately, no scintigraphic technique has been found sufficiently effective and feasible to replace the routine use of CT. 33 For example, when we studied 67m Ga scintigraphy and, later, the anticarcinoembryonic antigen monoclonal antibody scintigraphy, we obtained results that were often noteworthy but never really satisfactory. 22,23,25,[55][56][57][58][59] 99m TC-tetrofosmin is a new myocardial imaging agent with high affinity for cancer tissues. The mechanism of tumor uptake for this radiopharmaceutical is not clearly understood.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.